Related Experiment Video

Updated: Jun 16, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Micro-orchestrating differentiation in cancer

Riccardo Taulli1, Francesca Bersani, Carola Ponzetto

  • 1Department of Anatomy, Pharmacology and Forensic Medicine and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy.

Cell Cycle (Georgetown, Tex.)
|February 18, 2010
PubMed

Insights

MicroRNAs (miRNAs) may unlock cancer cell differentiation by targeting epigenetic modifiers. This approach could offer a non-toxic treatment strategy for solid tumors, similar to current therapies for blood cancers.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology
  • Gene Regulation

Background:

  • Cell differentiation involves epigenetic silencing of proliferation genes and activation of lineage-specific genes.
  • Cancer cells exhibit a transcriptionally inactive state for differentiation genes, hindering therapeutic approaches.
  • Current treatments for some hematologic malignancies utilize non-toxic differentiation induction.

Purpose of the Study:

  • To investigate the potential of microRNAs (miRNAs) in overcoming the differentiation block in cancer cells.
  • To explore the role of miRNAs in targeting epigenetic modifiers to restore gene expression.
  • To assess the feasibility of a miRNA-based differentiative therapy for solid tumors.

Main Methods:

  • Analysis of miRNA interactions with epigenetic modifier genes.
  • Experimental manipulation of miRNA expression in cancer cell models.
  • Assessment of gene expression changes related to differentiation and proliferation.

Main Results:

  • Identification of specific miRNAs capable of targeting key epigenetic regulators.
  • Demonstration that miRNA modulation can release the transcriptional block on differentiation genes.
  • Evidence suggesting that miRNAs can induce differentiation in cancer cells.

Conclusions:

  • MicroRNAs represent a promising therapeutic avenue for inducing cancer cell differentiation.
  • Targeting epigenetic modifiers with miRNAs offers a potential non-toxic strategy for solid tumors.
  • This approach could translate successful differentiative therapies from hematologic malignancies to solid cancers.

More Related Videos

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...